http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
-
Labcorp OnDemand Offers Menopause Test to Consumers
-
Labcorp Finalizes Strategic Relationship with Jefferson Health
-
Labcorp Declares Quarterly Dividend
-
Labcorp (LH) And Legacy Health Agree To Comprehensive Laboratory Relationship
-
LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP
-
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
-
Labcorp (LH) completed the spin-off of Fortrea (FTRE)
-
Labcorp Completes Spin-off of Fortrea
-
Labcorp to Announce Second Quarter Financial Results on July 27, 2023
-
Labcorp Awarded Forrester Research 2023 Customer Obsession Leadership Award
-
Labcorp (LH) Prices $570M Notes Offering Connected to Anticipated Fortrea Spinoff
-
LABCORP ANNOUNCES PRICING OF FORTREA $570 MILLION NOTES OFFERING IN CONNECTION WITH ANTICIPATED FORTREA SPINOFF
-
Labcorp (LH) Announces Additional Information in Connection with Fortrea Spin-off
-
LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA
-
Labcorp (LH) Announces Information in Connection with its Spin-off of Fortrea
-
Labcorp Announces Information in Connection with its Spin-off of Fortrea
-
Labcorp (LH) Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
-
Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
-
Labcorp (LH) Appoints Paul Rothman to its Board
-
Labcorp Appoints Dr. Paul Rothman to Board of Directors
-
Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day
-
Labcorp Plasma Focus™ Liquid Biopsy Test Now Available
-
Labcorp (LH) and Providence Expand Strategic Laboratory Relationship
-
Labcorp and Providence Expand Strategic Laboratory Relationship
-
LABCORP TO WEBCAST ITS ANNUAL MEETING OF SHAREHOLDERS
-
LABCORP AND JEFFERSON HEALTH ANNOUNCE STRATEGIC LABORATORY RELATIONSHIP
-
Labcorp Announces 2023 First Quarter Results
-
LABCORP DECLARES QUARTERLY DIVIDEND
-
LABCORP EXPANDS ACCESS TO COLORECTAL CANCER SCREENING THROUGH PARTNERSHIP WITH THE CONFERENCE OF NATIONAL BLACK CHURCHES
-
LABCORP TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS ON APRIL 25, 2023
-
Enzo Biochem (ENZ) to Sell Clinical Laboratory to Labcorp
-
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
-
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
-
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
-
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
-
Labcorp Declares Quarterly Dividend
-
Labcorp (LH) Announces Thomas Pike to Join as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
-
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
-
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
-
Labcorp Opens New Los Angeles Based Laboratory
-
Oracle Cerner Technology to Manage Hospital Labs in 10 States
-
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
-
Labcorp Announces 2022 Third Quarter Results
-
Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors
-
Labcorp Declares Quarterly Dividend
-
Labcorp Establishes Comprehensive Laboratory Relationship With Ascension
-
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
-
Labcorp to Speak at the Baird 2022 Global Healthcare Conference
-
Labcorp (LH) Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health
